Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data

Authors

  • David Pettersson a Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark
  • Frida E. Lundberg b Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  • Simon M. Kønig a Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark
  • Elínborg Ólafsdóttir c Icelandic Cancer Registry, Reykjavik, Iceland
  • Tom B. Johannesen d Cancer Registry of Norway, Oslo, Norway
  • David Pettersson e Swedish Cancer Registry, National Board of Health and Welfare, Stockholm, Sweden
  • Lina S. Mørch a Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark
  • Anna L. V. Johansson b Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; d Cancer Registry of Norway, Oslo, Norway
  • Søren Friis a Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark

DOI:

https://doi.org/10.1080/0284186X.2023.2189528

Keywords:

Cancer stage, TNM, algorithm, cancer survival, NORDCAN

Abstract

Background

The stage at diagnosis is one of the most important predictors for cancer survival. TNM stage is constructed from T (tumor size), N (nodal spread), and M (distant metastasis) components. In many notifications to cancer registries, TNM information is incomplete with unknown N and/or M. We aimed to evaluate the influence of various assumptions for recoding missing N (NX) and M (MX) as N0 and M0 on the proportion with available TNM stage, stage-distribution, and stage-specific relative survival.

Material and Methods

We identified 140,201 patients diagnosed with incident cancer of the colon, rectum, lung, breast, or kidney during 2014–2016 in Denmark, Norway, Sweden, or Iceland. Information on TNM were obtained from cancer registry records used for an update of the Nordic cancer statistics database NORDCAN. Patients were followed for death or emigration through 2017. We calculated proportions of available TNM stage, stage distribution, and stage-specific relative survival under different approaches for each cancer site and country.

Results

Application of the assumptions yielded higher numbers of cases with available TNM stage for stages 0–I, II, and III. We observed only minor differences in stage-specific one-year relative survival when applying N0M0 for missing N and M, especially for high completeness of TNM registrations, whereas relative survival for remaining cases with missing TNM stage declined substantially.

Conclusion

We found no major changes in stage-specific one-year relative survival applying N0M0 for NXMX. We conclude that complete TNM information is preferable to making assumptions, but it seems reasonable to consider assuming N0M0 for missing N and M in future studies based on the Nordic cancer registries. An automatic algorithm, though, is not recommended without considering potential area-specific reasons for frequent use of NX and MX. Clinicians should be urged to report complete TNM information to improve surveillance of the TNM stage.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-03-04

How to Cite

Pettersson, D., E. Lundberg, F., M. Kønig, S., Ólafsdóttir, E., B. Johannesen, T., Pettersson, D., … Friis, S. (2023). Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data. Acta Oncologica, 62(3), 215–222. https://doi.org/10.1080/0284186X.2023.2189528